CRISPR Library Screening FAQ: A Comprehensive Guide

CRISPR Library Screening FAQ: A Comprehensive Guide

CRISPR library screening is a core tool in functional genomics research. The workflow involves multiple complex steps, including CRISPR library construction and viral delivery. Drawing on extensive hands-on experience with CRISPR library screening, Ubigene addresses a range of frequently asked questions to help improve experimental success rates.

1. What is the difference between CRISPR Genome-wide Library A and Library B?

• Similarities: Both libraries are designed to target all protein-coding genes across the genome, with three distinct sgRNAs designed for each gene.
• Differences: In addition to targeting protein-coding genes, Genome-wide Library A also includes sgRNAs specifically designed to target microRNAs (miRNAs).

2. How to Choose an Appropriate CRISPR Library Type (Library Size, Gene Categories, sgRNA Number)?

• A larger number of sgRNAs in the library increases experimental workload and technical complexity.
• Designing more sgRNAs per gene improves the reliability and robustness of the screening results.
• A library covering a larger number of genes enables broader target coverage; however, it may also increase the likelihood of identifying false-positive and false-negative hits.

3. How to Ensure CRISPR Library Plasmid Coverage and Uniformity?

• Use electroporation for plasmid amplification to ensure high transformation efficiency. Ubigene employs proprietary bacterial strains and optimized electrocompetent cell preparation methods to achieve highly efficient plasmid electroporation.
• Perform multiple rounds of electroporation to ensure sufficient colony numbers. Colony counting should confirm a post-transformation coverage of >300×.

4. Can the CRISPR Library Cell Pool Transduced with an sgRNA Library Be Used Directly for Screening?

Yes. The purpose of CRISPR library screening is to apply selective pressure to enrich cells with desired phenotypes, followed by next-generation sequencing (NGS) to identify enriched sgRNAs and thereby determine target genes.

Before screening, it is critical to ensure that sgRNA representation in the cell pool exceeds 90%, ensuring that the vast majority of targets are retained. After applying selective pressure and enriching the target cell population, candidate genes can be identified.

5. What Types of Customized CRISPR Libraries can be provided by Ubigene?

Ubigene offers multiple customized CRISPR library formats, including: Single sgRNA libraries, Dual sgRNA libraries, AAV-based CRISPR libraries. In addition, plasmid vectors can be customized based on specific requirements such as fluorescent markers, selection markers (e.g., antibiotic resistance), and the presence or absence of Cas9.

6. What Are the Differences Between CRISPR Library Virus Packaging and Standard Viral Packaging, and How Is Viral Titer Ensured?

• In CRISPR library plasmid systems (Carry Cas9), the inserted sequences are longer, making viral packaging more challenging compared to standard viral vectors. Ubigene uses proprietary transfection media and optimized packaging systems to ensure high efficiency and viral titers.
• CRISPR Library viruses contain a diverse pool of sgRNAs; therefore, larger-scale packaging is required to maintain adequate sgRNA representation.

7. How Should CRISPR Library Viruses Be Stored, and What Is Their Shelf Life?

Because CRISPR library viruses contain diverse sgRNAs, improper storage or prolonged storage may result in the loss of low-abundance sgRNAs, reducing CRISPR library coverage.

• Store library viruses at −80 °C and avoid repeated freeze–thaw cycles.
• To maintain sgRNA representation, it is recommended to use the virus within 6 months. If stored longer, viral titer should be re-evaluated. Discard the virus if a significant drop in titer is observed.

8. Can CRISPR Library Cell Pools Be Passaged? If So, How Many Passages Are Recommended?

For screening applications that do not aim to identify essential genes, CRISPR library cell pools can be passaged. During passaging, it is recommended to recover and expand at least one aliquot corresponding to 300×–500× coverage. Cell expansion should be limited to within 5 passages to ensure sgRNA representation remains above 90% prior to screening.

9. Will High Cell Death During Thawing Affect CRISPR Library Coverage?

• Excessive cell death can negatively impact CRISPR library coverage. Proceeding directly to screening under such conditions may lead to the loss of critical target genes in the final results.
• Ubigene accounts for expected cell loss during shipment by providing excess cells. A cell death rate of up to 30% upon thawing is acceptable and does not compromise overall CRISPR library coverage.

10. How to Evaluate the Reliability of CRISPR Screening Results, and What Controls Should Be Included?

• CRISPR libraries typically include non-targeting sgRNAs as negative controls. In principle, these should not be enriched in either positive or negative selection screens.
• Positive control sgRNAs (expected to be enriched under specific screening conditions) should be included. Enrichment of positive controls confirms that the screening process is functioning as expected.

Because CRISPR screening lacks a clear definition of negative outcomes, positive controls are generally more critical than negative controls.